Kinnate Biopharma Inc.
KNTEDelisted Apr 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001797768
Kinnate Biopharma Inc. was delisted on Apr 3, 2024; its insiders filed their last Form 4 on Apr 5, 2024; 56 institutions reported holding it in 13F filings for Q1 2024, worth $92.2M in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Kinnate Biopharma Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- 0 vs. Q1 2021
- Shares held
- 38.3M
- +456.4K (+1.2%) vs. Q1 2021
- Total value
- $890.9M
- −$286.1M (−24.3%) vs. Q1 2021
- New holders
- 9
- 17 more added
- Sold out
- 9
- 20 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNTE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 56 | $92.2M |
| Q4 2023 | 62 | $91.0M |
| Q3 2023 | 59 | $54.0M |
| Q2 2023 | 72 | $121.4M |
| Q1 2023 | 71 | $270.4M |
| Q4 2022 | 79 | $249.0M |
| Q3 2022 | 84 | $520.8M |
| Q2 2022 | 73 | $543.5M |
| Q1 2022 | 76 | $464.9M |
| Q4 2021 | 71 | $750.5M |
| Q3 2021 | 74 | $905.1M |
| Q2 2021 | 62 | $890.9M |
| Q1 2021 | 62 | $1.18B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Kinnate Biopharma Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 19 | $0 | 0.00% | +19 | New |
| US Bancorp | 50 | $1.00K | 0.00% | +50 | New |
| Signaturefd, LLC | 59 | $1.00K | 0.00% | +59 | New |
| Wells Fargo & Company | 139 | $3.00K | 0.00% | −4,077−96.7% | Reduced |
| UBS Group AG | 252 | $6.00K | 0.00% | −536−68.0% | Reduced |
| Tower Research Capital LLC (TRC) | 648 | $15.0K | 0.00% | −2−0.3% | Reduced |
| Legal & General Group Plc | 1,123 | $26.0K | 0.00% | −247−18.0% | Reduced |
| Ameritas Investment Partners, Inc. | 1,099 | $26.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,403 | $33.0K | 0.00% | +408+41.0% | Added |
| Royal Bank of Canada | 2,012 | $48.0K | 0.00% | +224+12.5% | Added |
| STRS Ohio | 3,300 | $76.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,263 | $123.0K | 0.00% | −21,919−80.6% | Reduced |
| American International Group, Inc. | 7,598 | $177.0K | 0.00% | −279−3.5% | Reduced |
| JPMorgan Chase & Co | 8,147 | $189.0K | 0.00% | +3,079+60.8% | Added |
| New York State Common Retirement Fund | 13,111 | $305.0K | 0.00% | +5,811+79.6% | Added |
| Squarepoint Ops LLC | 13,272 | $309.0K | 0.00% | +13,272 | New |
| Ensign Peak Advisors, Inc | 15,000 | $349.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 15,212 | $354.0K | 0.00% | −2,562−14.4% | Reduced |
| Rhumbline Advisers | 15,455 | $360.0K | 0.00% | +3,758+32.1% | Added |
| California State Teachers Retirement System | 18,707 | $435.0K | 0.00% | −1,678−8.2% | Reduced |
| HRT Financial LP | 20,213 | $470.0K | 0.00% | +20,213 | New |
| D. E. Shaw & Co., Inc. | 20,757 | $483.0K | 0.00% | −2,088−9.1% | Reduced |
| Swiss National Bank | 24,000 | $559.0K | 0.00% | +24,000 | New |
| EcoR1 Capital, LLC | 25,000 | $582.0K | 0.02% | 00.0% | Unchanged |
| HighVista Strategies LLC | 33,391 | $777.0K | 0.55% | +33,391 | New |
| TD Asset Management Inc | 37,407 | $807.0K | 0.00% | −7,300−16.3% | Reduced |
| Renaissance Technologies LLC | 35,900 | $836.0K | 0.00% | +35,900 | New |
| Bank of New York Mellon Corp | 40,723 | $948.0K | 0.00% | +4,957+13.9% | Added |
| DAFNA Capital Management LLC | 54,415 | $1.27M | 0.26% | +1,500+2.8% | Added |
| Nuveen Asset Management, LLC | 57,743 | $1.34M | 0.00% | +8,557+17.4% | Added |
| Morgan Stanley | 87,053 | $2.03M | 0.00% | +87,053 | New |
| Charles Schwab Investment Management Inc | 90,050 | $2.10M | 0.00% | +1,409+1.6% | Added |
| Victory Capital Management Inc | 96,040 | $2.24M | 0.00% | −6,370−6.2% | Reduced |
| Artal Group S.A. | 125,000 | $2.91M | 0.07% | 00.0% | Unchanged |
| Deutsche Bank AG | 126,311 | $2.94M | 0.00% | +99,184+365.6% | Added |
| Northern Trust Corp | 135,513 | $3.15M | 0.00% | −10,095−6.9% | Reduced |
| American Century Companies Inc | 173,719 | $4.04M | 0.00% | +248+0.1% | Added |
| Franklin Resources Inc | 192,100 | $4.47M | 0.00% | +17,093+9.8% | Added |
| State Street Corp | 237,130 | $5.52M | 0.00% | +53,848+29.4% | Added |
| Geode Capital Management, LLC | 237,249 | $5.52M | 0.00% | −1,332−0.6% | Reduced |
| Woodline Partners LP | 260,276 | $6.06M | 0.11% | −25,853−9.0% | Reduced |
| PFM Health Sciences, LP | 264,293 | $6.15M | 0.20% | 00.0% | Unchanged |
| Novo Holdings A/S | 300,000 | $6.98M | 0.31% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 307,800 | $7.17M | 0.01% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 331,586 | $7.72M | 0.15% | +5,200+1.6% | Added |
| Price T Rowe Associates Inc | 445,477 | $10.4M | 0.00% | −203,305−31.3% | Reduced |
| Harvard Management Co Inc | 498,001 | $11.6M | 0.67% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 602,736 | $13.5M | 0.01% | −197,538−24.7% | Reduced |
| Foresite Capital Management V, LLC | 875,001 | $20.4M | 8.01% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,020,000 | $23.7M | 0.42% | +675,000+195.7% | Added |
| Boxer Capital, LLC | 1,065,939 | $24.8M | 0.88% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,188,830 | $27.7M | 0.00% | −117,091−9.0% | Reduced |
| BlackRock Inc. | 1,273,529 | $29.6M | 0.00% | +63,331+5.2% | Added |
| Citadel Advisors LLC | 1,300,887 | $30.3M | 0.03% | −14,763−1.1% | Reduced |
| Logos Global Management LP | 1,329,602 | $31.0M | 2.65% | +395,000+42.3% | Added |
| VR Adviser, LLC | 1,473,014 | $34.3M | 4.16% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,820,462 | $42.4M | 0.13% | −51,561−2.8% | Reduced |
| FMR LLC | 2,105,021 | $49.0M | 0.00% | −26,627−1.2% | Reduced |
| Vida Ventures Advisors, LLC | 2,747,433 | $64.0M | 16.04% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,593,052 | $83.6M | 1.34% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,847,929 | $89.6M | 0.92% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 9,671,643 | $225.2M | 30.43% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −109,000−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −13,198−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −7,566−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −7,620−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −6,421−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,693−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −419−100.0% | Sold out |